TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Farmastat Norsk Legemiddelstatistikk AS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
21,334
|
21,687
|
21,506 |
Financial expenses |
118
|
80
|
14 |
Earnings before taxes |
-471
|
34
|
872 |
Total assets |
11,211
|
13,107
|
13,924 |
Current assets |
6,737
|
8,471
|
8,468 |
Current liabilities |
3,363
|
4,158
|
5,164 |
Equity capital |
7,673
|
8,646
|
8,353 |
- share capital |
1,974
|
2,114
|
2,051 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
68.4%
|
66.0%
|
60.0% |
Turnover per employee | |||
Profit as a percentage of turnover |
-2.2%
|
0.2%
|
4.1% |
Return on assets (ROA) |
-3.1%
|
0.9%
|
6.4% |
Current ratio |
200.3%
|
203.7%
|
164.0% |
Return on equity (ROE) |
-6.1%
|
0.4%
|
10.4% |
Change turnover |
1,084
|
-485
|
3,084 |
Change turnover % |
5%
|
-2%
|
17% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.